CMV test kit Aptima®

herpesHBVHCV

Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. CMV, a member of the herpes virus family, establishes a lifelong latent infection that is generally asymptomatic. However, in immunocompromised patients, such as transplant recipients, reactivation of latent CMV is often life-threatening. Guidelines recommend regular monitoring of CMV viral load as an aid for diagnosis of CMV infections and monitoring response to treatment. The Aptima CMV Quant assay intended use is to: Monitor Viral Load Assess viral response to treatment with serial DNA measurements in patients receiving anti-CMV therapy. Inform Care Aid in the management of solid-organ transplant patients and hematopoietic stem cell transplant patients. Excellent performance for high-quality results Deliver accurate, consistent, and clinically actionable viral load insights with our extensively-validated quantitative CMV assay. Sensitivity: LoD – 40.7 IU/mL plasma LLoQ – 53 IU/mL plasma One reliable partner Trust in a single lab partner to maximize your lab’s operational efficiencies. Expanding menu With 19 FDA-approved assays and an ever growing menu with 7 assays in development, you can now integrate and consolidate transplant and core viral load assays on a single high-throughput system. Consolidation efficiencies Help reduce LIS connection costs, streamline tech training, and drive cost efficiencies in lab purchasing and resource management with consolidation of platforms. Excellent customer service Our award-winning customer service means you are one call away from a large team that supports all your reagent needs.